Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies

Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies

Abstract In a pilot study, we evaluated the feasibility of real-time deep analysis of serial tumor samples from triple negative breast cancer patients to identify mechanisms of resistance and treatment opportunities as they emerge under therapeutic stress engendered by poly-ADP-ribose polymerase (PA...

Full description

Bibliographic Details
Main Authors:	Marilyne Labrie, Allen Li, Allison Creason, Courtney Betts, Jamie Keck, Brett Johnson, Shamilene Sivagnanam, Christopher Boniface, Hongli Ma, Aurora Blucher, Young Hwan Chang, Koei Chin, Jacqueline Vuky, Alexander R. Guimaraes, Molly Downey, Jeong Youn Lim, Lina Gao, Kiara Siex, Swapnil Parmar, Annette Kolodzie, Paul T. Spellman, Jeremy Goecks, Lisa M. Coussens, Christopher L. Corless, Raymond Bergan, Joe W. Gray, Gordon B. Mills, Zahi I. Mitri
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-10-01
Series:	npj Precision Oncology
Online Access:	https://doi.org/10.1038/s41698-021-00232-w

Similar Items

Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics
by: Allen Li, et al.
Published: (2021-03-01)

Single-cell spatial architectures associated with clinical outcome in head and neck squamous cell carcinoma
by: Katie E. Blise, et al.
Published: (2022-02-01)

Single-Cell Proteomics Analysis of Recurrent Low-Grade Serous Ovarian Carcinoma and Associated Brain Metastases
by: Tanja Pejovic, et al.
Published: (2022-05-01)

Implementing a comprehensive translational oncology platform: from molecular testing to actionability
by: Zahi I. Mitri, et al.
Published: (2018-12-01)

The Landscape of Targeted Therapies in TNBC
by: Elena Vagia, et al.
Published: (2020-04-01)

PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway
by: Yuanzhen Ma, et al.
Published: (2024-04-01)

Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
by: Aiswarya Chaudhuri, et al.
Published: (2023-05-01)

Aptamer-Based Strategies to Boost Immunotherapy in TNBC
by: Lisa Agnello, et al.
Published: (2023-03-01)

The Potential of PSMA as a Vascular Target in TNBC
by: Amelie Heesch, et al.
Published: (2023-02-01)

Immuno-oncology treatment in early stage TNBC
by: S. Loi
Published: (2021-04-01)

Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro
by: Hoon Sik Choi, et al.
Published: (2021-08-01)

Unrevealing the Role of miRNA in Successful TNBC Treatment: A Pilot Study to Explore the Chemotherapy Drugs for Timely Treatment of TNBC
by: Poulami Sarkar, et al.

Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target
by: Malvina Koni, et al.
Published: (2022-08-01)

LC–MS Based Lipidomics Depict Phosphatidylethanolamine as Biomarkers of TNBC MDA-MB-231 over nTNBC MCF-7 Cells
by: Alan Rubén Estrada-Pérez, et al.
Published: (2022-10-01)

Optimization of Short RNA Aptamers for TNBC Cell Targeting
by: Simona Camorani, et al.
Published: (2022-03-01)

Heme Oxygenase Modulation Drives Ferroptosis in TNBC Cells
by: Valeria Consoli, et al.
Published: (2022-05-01)

TNBC Therapeutics Based on Combination of Fusarochromanone with EGFR Inhibitors
by: Natalie Carroll, et al.
Published: (2022-11-01)

An Magnetic-Targeting Nano-Diagnosis and Treatment Platform for TNBC
by: Zhang M, et al.
Published: (2023-02-01)

Recurrent triple-negative breast cancer (TNBC) tissues contain a higher amount of phosphatidylcholine (32:1) than non-recurrent TNBC tissues.
by: Yuko Hosokawa, et al.
Published: (2017-01-01)

Multiomic Investigations into Lung Health and Disease
by: Sarah E. Blutt, et al.
Published: (2023-08-01)

Recent Multiomics Approaches in Endometrial Cancer
by: Dariusz Boroń, et al.
Published: (2022-01-01)

The role of physics in multiomics and cancer evolution
by: Lucie E. Gourmet, et al.
Published: (2023-03-01)

Microfluidic single‐cell multiomics analysis
by: Xing Xu, et al.
Published: (2023-02-01)

Tendon and multiomics: advantages, advances, and opportunities
by: Paula Sarmiento, et al.
Published: (2021-10-01)

Multiview learning for understanding functional multiomics.
by: Nam D Nguyen, et al.
Published: (2020-04-01)

Multiomics kaleidoscope to visualize cancer hallmarks
by: Shengtao Zhou
Published: (2020-10-01)

Cdh1 Deficiency Sensitizes TNBC Cells to PARP Inhibitors
by: Junjun Li, et al.
Published: (2022-04-01)

Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance
by: Desh Deepak Singh, et al.
Published: (2021-10-01)

Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC
by: Paola Ferrari, et al.
Published: (2022-01-01)

Kaiso Protein Expression Correlates with Overall Survival in TNBC Patients
by: Artur Bocian, et al.
Published: (2023-01-01)

VISTA is associated with immune infiltration and predicts favorable prognosis in TNBC
by: Mi Zhang, et al.
Published: (2022-09-01)

Accelerating progress from advanced to early breast cancer for TNBC
by: G. Curigliano
Published: (2021-04-01)

TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities
by: Simona Camorani, et al.
Published: (2018-11-01)

Deciphering the Immune Complexity in Esophageal Adenocarcinoma and Pre-Cancerous Lesions With Sequential Multiplex Immunohistochemistry and Sparse Subspace Clustering Approach
by: Srinand Sundaram, et al.
Published: (2022-05-01)

P331: Multiomic approach to diagnosis: A case study in the Undiagnosed Diseases Program
by: Anna Crowell, et al.
Published: (2024-01-01)

Advances in Multiomic Analyses of Frailty Biomarkers in the Elderly
by: XU Ting, JI Minghui, CHEN Yimeng, GAO Yu, ZHU Hanfei, DING Lingyu, XU Qin
Published: (2023-08-01)

Multiomics Topic Modeling for Breast Cancer Classification
by: Filippo Valle, et al.
Published: (2022-02-01)

Single-Cell Multiomics Analysis for Drug Discovery
by: Sam F. Nassar, et al.
Published: (2021-10-01)

Multiomic landscape of immune pathogenesis in Kimura’s disease
by: Xunyao Wu, et al.
Published: (2023-04-01)

Approaches to Computational Strain Design in the Multiomics Era
by: Peter C. St. John, et al.
Published: (2019-04-01)